They further elucidate the role of NEU1 siRNA, which via targeting lysosome and oxidative phosphorylation signaling, effectively inhibits the proliferation, apoptosis, and invasion of human ovarian cancer cells suggesting NEU1 can be targeted for the treatment of ovarian cancer [66]. Here, NEU1 is linked to ovarian cancer.